C3is (NASDAQ:CISS) Upgraded to “Sell” at Wall Street Zen

Wall Street Zen upgraded shares of C3is (NASDAQ:CISSFree Report) to a sell rating in a research note published on Saturday morning.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of C3is in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, C3is currently has a consensus rating of “Sell”.

Get Our Latest Stock Report on CISS

C3is Stock Down 5.6%

Shares of CISS stock opened at $1.85 on Friday. The stock has a 50-day simple moving average of $8.60 and a 200 day simple moving average of $35.15. The stock has a market capitalization of $1.89 million, a P/E ratio of -0.01 and a beta of 1.96. C3is has a fifty-two week low of $1.35 and a fifty-two week high of $151.20.

Hedge Funds Weigh In On C3is

A hedge fund recently raised its stake in C3is stock. Wexford Capital LP raised its position in shares of C3is Inc. (NASDAQ:CISSFree Report) by 460.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 112,014 shares of the company’s stock after purchasing an additional 92,014 shares during the quarter. Wexford Capital LP owned 6.29% of C3is worth $240,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 10.54% of the company’s stock.

C3is Company Profile

(Get Free Report)

C3is Inc offers international seaborne transportation services. It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers. The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil.

Featured Articles

Receive News & Ratings for C3is Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3is and related companies with MarketBeat.com's FREE daily email newsletter.